Feedback
Settings

Settings

Goto Application

1. WO2020250209 - LACTOFERRIN FOR ORAL USE WITH ANTIVIRAL ACTION

Submit observation
PermaLink
Publication Number WO/2020/250209
Publication Date 17.12.2020
International Application No. PCT/IB2020/059695
International Filing Date 15.10.2020
IPC
A61K 38/40 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
40Transferrins, e.g. lactoferrins, ovotransferrins
A61P 31/12 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
CPC
A61K 35/744
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
A61K 38/40
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
40Transferrins, e.g. lactoferrins, ovotransferrins
A61P 31/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
Applicants
  • SOFAR S.P.A. [IT]/[IT]
Inventors
  • BIFFI, Andrea
  • FIORE, Walter
Agents
  • HOFFMANN EITLE S.R.L.
  • ZANGS, Rainer E.
  • KINDLER, Matthias
  • FRANK, Veit Peter
  • POLZ, Leo
  • STEIN-DRÄGER, Christiane
  • AVERY, Stephen John
  • LETHEM, David James
  • MARSH, Roy David
  • MITCHELL, Alan
  • FURLONG, Christopher Heinrich
  • BAUSCH, Thorsten
  • TAORMINO, Joseph Paul
  • KLUSMANN, Peter
  • SCHWEIGHART, Peter
  • WOLF, Matthias
  • SIEGERT, Georg
  • MAYRHOFER, Stefan
  • STRATMANN, Klemens
  • WIEDEMANN, Peter
  • VON KUROWSKI, Lorenz
  • BECHER, Claus Thomas
  • SPILGIES, Jan-Hendrik
  • RENKEN, Joachim
  • ENGELHARD, Elisabeth
  • BACHELIN, Karl Martin Raimund
  • DISSER, Stephan
  • VAN BOUWELEN, Franciscus Maria
  • FÜCHSLE, Kathrin
  • CIESLA, Ulrike
  • SCHÖN, Anne Katrin
  • VOCKE, Henrik
  • GÖRG, Andreas
  • GARBERG, Morten
  • RUSSELL, John Alistair
  • SPROSTON, David
  • THIRLWELL, Karen
  • SCHEIBLE, Dominik
  • VOS, Bianca-Lucia
  • DOUXCHAMPS, Nicolas
  • STEFFERL, Andreas
  • GOLLER, Daniel
  • PRUSS, Timo
  • WERNER-JONES, Leonard L.
  • BACCELLI, Michele
  • MÜLLER, Markus Georg
  • MUNCKE, Nadja
  • CORNEO, Giovanni
  • STREGE, Christine
  • DRAGOSAVAC, Marko
  • BIRKETT, Matthew
  • ZILLIES, Jan Carl
  • GROHS, Daniel
  • MULHERN, Declan
  • GRIMM, Stephan
  • TILLMANN, Volker
  • OGLE, James Matthew
  • GLAS, Johannes Dominik
  • STEINMÜLLER, Stephan
  • BENEDETTO, Marco
  • LEVINE, Benjamin
  • JONES, Mark A. G.
  • GRAEBER, Jens
  • FUSTER, Gustavo
  • ESSER, Axel T.
  • SCHIEREN, Roland
  • RECKENTHÄLER, Peter
  • CATANIA, Olivier
  • DÖRFEL, Katrin
  • WEINMANN, Lasse
  • SASSE, Stefan
  • MACHOTTA, Axel
  • SCHREIBER, Christian
  • WYDER, Thomas
  • WEIGEL-KRUSEMARCK, Michaela
  • MÜLLER, Michael
  • LEWIS, Debra Louise
  • PAETZOLD, Helge
  • SPIRKOSKA, Danche
Priority Data
10202000000501109.03.2020IT
Publication Language English (en)
Filing Language Italian (IT)
Designated States
Title
(EN) LACTOFERRIN FOR ORAL USE WITH ANTIVIRAL ACTION
(FR) LACTOFERRINE À USAGE ORAL AYANT UNE ACTION ANTIVIRALE
Abstract
(EN) The present invention relates to a composition comprising lactoferrin for oral use as an antiviral, preferably for use in the treatment of viral infections of the respiratory system and of symptoms or disorders deriving from, or relating to, said viral infections, preferably SARS-coronavirus viral infections (e.g. COVID-19).
(FR) La présente invention concerne une composition comprenant de la lactoferrine pour une utilisation orale en tant qu'antiviral, de préférence destinée à être utilisée dans le traitement d'infections virales du système respiratoire et de symptômes ou de troubles dérivant des infections virales, ou se rapportant aux infections virales, de préférence des infections virales du coronavirus SRAS (par exemple, (e.g. COVID-19).
Latest bibliographic data on file with the International Bureau
# -